C-Reactive Protein Test Market, By Type of Assays (ELISA, Immunoturbidimetric, Chemiluminescence Immunoassay(CLIA), and High-sensitivity C-reactive Protein (hsCRP) assay), By Application (Cardiovascular Diseases, Infections, Diseases of Immune System, Rheumatoid Arthritis, Cancers, Inflammatory Bowel Disease, and Osteomyelitis), By End-User (Hospitals, Diagnostic Centres, CRO, and Academic and Research Institutes), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

C-Reactive Protein Test Market was valued at US$ 2.3 billion in 2024 and is projected to grow at a CAGR of 5.3% to reach US$ 3.8 billion by 2034.

A C-reactive protein (CRP) test is a simple blood test that measures the level of C-reactive protein (CRP) in a patient’s blood. CRP is a protein made by the liver in response to inflammation in the body. High levels of CRP may indicate a serious health condition that causes inflammation, such as: Infections, Autoimmune diseases, certain cancers and heart diseases. A C-Reactive Protein test can also be used to monitor the effectiveness of treatment for conditions that cause inflammation.
The C-Reactive Protein (CRP) test market is a growing sector within the healthcare industry, fuelled by its crucial role in diagnosing and managing various conditions as chronic ailments such as coronary heart diseases, bacterial pneumonia and rheumatoid arthritis are on the rise post COVID-19.  According to the CDC (Centre for Disease Control and Prevention), in the United States, around 697,000 people died from heart disease, and around 20.1 million adults aged 20 and older are suffering from coronary artery disease (CAD), detection and treatment for which requires extensive C-Reactive Protein testing which in turn supports the growth of the current C-Reactive Protein Test Market.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

The C-Reactive Protein (CRP) test market key Drivers:

• Rising prevalence of chronic inflammatory diseases

Conditions like cardiovascular disease, arthritis, and autoimmune disorders drive demand for C-Reactive Protein tests as monitoring inflammation, a hallmark of many chronic conditions using elevated CRP levels as indicators helps guide treatment decisions. C-Reactive Protein test helps in Disease Activity and Prognosis as CRP levels can fluctuate in response to disease activity. Monitoring these changes helps assess disease severity, predict flare-ups, and evaluate treatment response. C-Reactive Protein testing also helps in guiding treatment choices by predicting possible disease complications and personalizing treatment intensity to accurately assess overall health status.

According to the CDC (Centre for Disease Control and Prevention), every year, about 805,000 people have a heart attack in the United States alone. About 695,000 people in the United States died from heart disease in 2021 alone.

• Technological advancements

Development of point-of-care (POC) devices offering rapid and near-patient C-Reactive Protein testing facilitates faster diagnosis and management, particularly in critical care settings. Advancement in nanotechnology is predicted to enable the development of portable bioanalytical assays with high specificity and multiplexing capacity to allow varied application of C-Reactive Protein tests and increase market growth.

• Growing geriatric population

As the elderly population with higher susceptibility to diabetes, respiratory infections and inflammation increases, demand for the C-Reactive Protein test market is expected to rise due to the preference for easily accessible, low cost, efficient home care treatment that provides accurate real time results.

The C-Reactive Protein (CRP) test market Restrains:

• Lack of awareness and availability of alternate testing methods

The wide availability of alternate testing methods with higher accuracy results such as Ultrasound tests and E.C.G tests for detection of cardiovascular diseases as well as other specific tests for different ailments can become a restraining factor for C-Reactive Protein Test market growth.

Recent Development:

• In March 2023, TransAsia Bio-Medicals Ltd. announced the launch of a line of specialised Make in India test kits, Erba CRP and Erba HbA1c. These clinical chemistry test kits aim to bring affordable point of care testing to over fifty thousand diagnostic laboratories and enhance overall patient care by providing better diagnostic capabilities in clinical labs across India.
• In July 2022, Bloom Diagnostics introduced a new Inflammation test that allows patients to measure their CRP quickly and accurately. The test allows ease of handling due to its semi-automatic nature and provides five different classifications for the CRP content in blood stream, ranging from normal which indicates regular CRP levels to high-grade inflammation denoted by abnormal C-Reactive Protein content.
• In January 2022, LumiraDx launched rapid micro fluidic immunoassay C-Reactive Protein (CRP) point of care test as a means to combat antimicrobial resistance in south east Asia especially India. This test is a means to provide POC services to patients with the assurance of quality testing and accurate results. The test can be applied to a variety of clinical settings and allows medical experts to make informed diagnostic decisions and lower the need for prescribing antibiotics.

C - reactive protein Test Market is segmented based on Type of Assays, By Application, By End-User and By Region.

Assay Type Insight 
On the basis of Type of Assays, C-Reactive Protein Test Market is segmented into Enzyme linked Immunosorbent Assay (ELISA), Immunoturbidimetric, Chemiluminescence Immunoassay(CLIA), and High-sensitivity C-reactive Protein (hsCRP) assay. Of these the Enzyme linked Immunosorbent Assay (ELISA) segment is dominating the current market and accounts for nearly 35% of the total market revenue. This is due to the high accuracy and versatile applications of the ELISA test as well as its ease of automation. Another reason is that ELISA can be used for both qualitative and quantitative analysis and is relatively cheap and easy to handle.
Application Insights
On the basis of Applications, C-Reactive Protein Test Market is segmented into Cardiovascular Diseases, Infections, Diseases of Immune System, Rheumatoid Arthritis, Cancers, Inflammatory Bowel Disease, and Osteomyelitis. Of these, the cardiovascular diseases segment has been dominating the current market and is expected to continue generating the highest income due to the growing number of cases of coronary artery disease across the globe. With the increase in global geriatric population and the COVID 19 pandemic, the inflammatory disease as well as Diseases of the Immune System segments will also expand in the current analysis period.
End User Insights:
On the basis of End Users, the C-Reactive Protein Test Market is segmented into Hospitals, Diagnostic Centres, CRO, and Academic and Research Institutes. Of these the Hospital sector shows the maximum growth, especially due to the adoption of C-Reactive Protein testing in hospitals in developing regions across the world. The Diagnostic Centres segment is also set to show rapid expansion as more patients opt for easily accessible home care and POC services.

Regional Insights:

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
C-Reactive Protein Test Market Regional Insights:

On region the C-Reactive Protein Test Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. 

• North America market is estimated to witness a significantly high revenue share in the forecast period, owing to the rising prevalence of chronic inflammatory diseases, coronary heart diseases, cancer diseases, the presence of majority of key players, technological advancement and collaboration between market participants for development of better test methods, increasing research & development activities, robust healthcare infrastructure and new investments.
• Asia Pacific market is estimated to witness fastest revenue share due to growing adoption of advanced technology in medical field, rising prevalence of disease cases especially chronic inflammatory diseases and cardiovascular diseases, and recent investments towards improving healthcare infrastructure. 
   

Report Scope:

Attribute	Details
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	By Type of Assays- Enzyme linked Immunosorbent Assay (ELISA), Immunoturbidimetric assay, Chemiluminescence Immunoassay (CLIA), and High-sensitivity C-reactive Protein (hsCRP) assay By Applications- Cardiovascular Diseases, Infections, Diseases of Immune System, Rheumatoid Arthritis, Cancers, Inflammatory Bowel Disease, Osteomyelitis. By End User- Hospitals, Diagnostic Centres, CRO, and Academic and Research Institutes
Regional scope	North America- U.S., Canada Europe- UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific- Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America- Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa- South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the C-Reactive Protein Test Market report based on Type of Assays, Application, End-User and by Region

C-Reactive Protein Test Market, By Type of Assay:

• Enzyme linked Immunosorbent Assay (ELISA)
• Immunoturbidimetric assay
• Chemiluminescence Immunoassay(CLIA)
• High-sensitivity C-reactive Protein (hsCRP) assay

C-Reactive Protein Test Market, By Applications:

• Cardiovascular Diseases, Infections
• Diseases of Immune System
• Rheumatoid Arthritis
• Cancers
• Inflammatory Bowel Disease
• Osteomyelitis

C-Reactive Protein Test Market, By End User:

• Hospitals
• Diagnostic Centres
• CRO
• Academic and Research Institutes

C-Reactive Protein Test Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Company Profile:

• Roche Diagnostics Corp.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Siemens Healthineers AG
• EMD Millipore Corp.
• Life technologies Corp.
• Randox Laboratories Ltd.
• Quest Diagnostics India Pvt Ltd.
• Abaxis, Inc.
• Thermo Fisher Scientific, Inc.
• Merck KgaA
• Abbott

“*” marked represents similar segmentation in other categories in the respective section

The key players operating the C-Reactive Protein Test Market includes, Roche Diagnostics Corp., Siemens Healthineers AG, EMD Millipore Corp., Life technologies Corp., Randox Laboratories Ltd., Quest Diagnostics India Pvt Ltd., Abaxis, Inc., Thermo Fisher Scientific Inc., Abbott and Others.

"

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
   • PORTER’s
   • Investment Outlook
3. Market Purview
   • Executive Summary
   • Key Findings—Global Outlook for C-Reactive Protein Test Strategies
     • Key Questions this Study will Answer

     • • By Type of Assays (ELISA, Immunoturbidimetric, Chemiluminesence Immunoassay(CLIA), and High-sensitivity C-reactive Protein (hsCRP) assay)

       • By Application (Cardiovascular Diseases, Infections, Diseases of Immune System, Rhematoid Arthritis, Cancers, Inflammatory Bowel Disease, and Osteomyelitis)

       • By End-User (Hospitals, Diagnostic Centers, CRO, and Academic and Research Institutes)

       • By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Overview
   • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
   • Y-o-Y Growth Analysis (%), 2020 – 2030
   • Regional Trends
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Regional Analysis
   • Regional Revenue Analysis
   • Regional By segment Analysis
   • Reasons for regional growth
   • Key Player of particular region
   • Countries Include in the report:

1. • • North America (U.S., Canada)
     • Europe (UK, France, Germany, Russia, Italy, Rest of Europe)
     • Asia Pacific (India, Japan, South Korea, China, Rest of Asia Pacific)
     • Latin America (Brazil, Mexico, Rest of Latin America)
     • Middle East & Africa (GCC, Israel, South Africa, Rest of Middle East)

1. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
   • Competitive Overview
   • Competitive Benchmarking
   • Market Share Analysis
   • Key Developments In The Global C-Reactive Protein Test Market
   • Key Developments: Mergers & Acquisitions
   • Key Developments: Collaboration
   • Key Developments: Contracts & Agreements
   • Key Developments: Expansion
   • Key Developments: Product Developments
2. Company Profiles

 

• Company Overview
• Product Portfolio
• Key Highlights
• Financial Performance
• Business Strategies
• SWOT Analysis

• • Roche Diagnostics Corp.
  • EMD Millipore Corp.
  • Life technologies Corp.
  • Randox Laboratories Ltd.
  • Quest Diagnostics India Pvt Ltd.
  • Abaxis, Inc.

1. The Last Word
   • Future Impact
   • About Us
   • Contact

"